Remove Immunization Remove Insurance Remove Webinar
article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. was powered by the advent of immune-checkpoint inhibitors, added Chalk.

article thumbnail

Medicare Beneficiaries in Underserved Areas and Pharmacist Provider Status

Omnicell

For essential services such as immunizations and diabetes care, people in underserved communities, which are often rural, must travel far from home. Even though local pharmacists already provide these services to commercially insured populations, Medicare Part B does not directly reimburse pharmacists.